Article
Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B
John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker, John Su, JoAnn D. Bradley, Rosie Z. Yu, Emil Chuang, Mark J. Graham, Rosanne M. Crooke
https://doi.org/10.1161/CIRCULATIONAHA.105.606442
Circulation. 2006;
Originally published October 9, 2006John J.P. Kastelein
Mark K. Wedel
Brenda F. Baker
John Su
JoAnn D. Bradley
Rosie Z. Yu
Emil Chuang
Mark J. Graham
Jump to

This is a PDF-only article. The first page of the PDF of this article appears below.

Current Issue
Jump to
Article Tools
- Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein BJohn J.P. Kastelein, Mark K. Wedel, Brenda F. Baker, John Su, JoAnn D. Bradley, Rosie Z. Yu, Emil Chuang, Mark J. Graham and Rosanne M. CrookeCirculation. 2006;, originally published October 9, 2006https://doi.org/10.1161/CIRCULATIONAHA.105.606442
Citation Manager Formats
Share this Article
- Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein BJohn J.P. Kastelein, Mark K. Wedel, Brenda F. Baker, John Su, JoAnn D. Bradley, Rosie Z. Yu, Emil Chuang, Mark J. Graham and Rosanne M. CrookeCirculation. 2006;, originally published October 9, 2006https://doi.org/10.1161/CIRCULATIONAHA.105.606442